Saturday, August 30, 2008
pehel.com
Home Latest News Pakistan World Science / Technology Sports Entertainment Health Business


Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years
Source: Medical News Today E-Mail this News Story to a friend E-Mail this Story
Category: Health
Publication Date: Sat, 17 May 2008 00:00:00 PDT
News URL: http://www.medicalnewstoday.com/articles/107748.php
Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 YearsPremalignant phases of prostate cancer occur over long periods of time and a single prostate-specific antigen (PSA) reading taken at age 44-50 can help predict prostate cancer diagnosis up to 30 years subsequently, according to updated data from researchers in New York and Malmo, Sweden. The findings expand the previously established baseline age-to-diagnosis interval.
Click here for full Story
http://www.medicalnewstoday.com/articles/107748.php
Bookmark this news story online:
Add Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to BlinkListAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to DeliciousAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to DiggAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to FarkAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to FurlAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to BlogarithmAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to MeneameAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to My Yahoo!Add Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to ReddItAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to ShadowsAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to SimpyAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to SpurlAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to Sync2ItAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to MagnoliaAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to NewsVineAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to Ask Jeeves
Add Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to Raw SugarAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to DiigoAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to NetVouzAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to Stumble UponAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to SegnaloAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to Google BookmarksAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to Microsoft LiveAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to BlogMarksAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to WinkAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to TechnoratiAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to Feed Me LinksAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to LinkaGoGoAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to BlueDotAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to Mister WongAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to TailRankAdd Baseline PSA Reading A Reliable Prostate Cancer Predictor For Up To 30 Years to Yahoo Bookmarks

Comments

No comments found... be the first one to comment on this story :)

Post a Comment
Name:
   
E-Mail Address:
   
Website / Blog URL (optional):
   
Comments:
   
Security Code:
   
  
   By submitting these comments, you are agreeing to our Terms of Service
    
Latest News
Latest News World News Pakistan News Technology News Entertainment News Business News Sports News
bullet Repair Stem Cell Institute Says Stanford University's Stem Cell Study Confirms The Futility Of Embryonics In Human Therapy
bullet Pediatric Heart Transplants At Montefiore Approved By NY State Department Of Health
bullet By Altering Hundreds Of Genes, Black Raspberries Slow Cancer
bullet Orthopaedic Surgeons Play Key Role In Stroke Recovery
bullet Digital Pathology Leader Adds Third FDA Clearance For Digital Pathology In Breast Cancer
bullet Heart Risk Due To Low Radiation Doses Worth Investigating Say Scientists
bullet Magnesium Sulphate May Reduce Cerebral Palsy
bullet Catheter Procedures Guided By Tiny 3-D Ultrasound Probe
bullet Doctors Concerned About Risk Of Repeat Attacks In Heart Patients
bullet Jumping For Joy ... And Stronger Bones
bullet UT Southwestern Researchers Find Antidepressants Need New Nerve Cells To Be Effective
bullet Guideline On Diagnosis And Treatment Of Primary Aldosteronism Released By Endocrine Society
bullet American Diabetes Wholesale Announces 2008 Diabetes Educator Of The Year Contest
bullet Morphotek(R), Inc. Expands Its Phase II Trial Site Selections In The European Union - Pancreatic Cancer Treatment
bullet Cook Medical Announces Rapid Adoption Of Its Breakthrough EVOLUTION(R) Device Designed To Remove Faulty Pacemaker Leads
bullet New Therapies Increasingly Being Used To Treat Liver Cancer
bullet MarkMonitor Reports Continuing Rise In Online Abuse Of Top Drug Brands
bullet Cancer - Curis Announces Dosing Of First Patient In Phase I Clinical Trial Of CUDC-101
bullet Class Of Diabetes Drugs Carries Significant Cardiovascular Risks
bullet Randomized Phase 2 Study Of IMC-A12 And IMC-1121B For Advanced Prostate Cancer Commences Patient Enrollment
bullet Experimental Therapy May Lead To Macular Degeneration
bullet Interventional Ophthalmology Procedure Indicated For Treatment Of Glaucoma
bullet ADAGIO Trial Results Show Teva's AZILECT(R) 1 Mg Tablets Slow Progression Of Parkinson's Disease
bullet Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks
bullet Even Without Dementia, Mental Skills Decline Years Before Death
 
© 2007 Verge Systems